Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTS.L Regulatory News (WTS)

  • There is currently no data for WTS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on new business activity

27 Dec 2017 07:00

RNS Number : 2759A
World Trade Systems PLC
22 December 2017
 

World Trade Systems PLC

22 December 2017

 

 

WORLD TRADE SYSTEMS PLC ("WTS plc")

UPDATE ON NEW BUSINESS ACTIVITIES

The Board of WTS plc announce their intentions to further develop and implement their global business strategy. Since the formation of WTS China in the middle of 2016, the main focus has been on the successful development of the business of distributing its heath food products in China. The Company has also communicated the second element of its plans to expand the international side of its business through partnership with established international product companies to distribute those products in China. Progress is being made on this and the strategy will evolve further into related health care services as well as products.

On the product side the Company has previously announced a memorandum of understating with Naturemed GmbH and is pleased to update that an agreement has now been reached in relation to the proposed commercialisation of its products in China. Naturemed GmbH is a company with limited liability established in September 2016 and managed by Director Dr. med. Dhalia-Rosa Smolczyk. Naturemed sells personal hygiene and dietary supplements manufactured from natural plant and animal origin in compliance with the provisions of the Medicines Act and the Pharmacy Act, in Germany and abroad.

 

WTS plc has entered into an arrangement with two other German companies related to NatureMed GmbH: Cordero GmbH & Co. KG and Humanio GmbH. Both of these companies are linked via their involvement in business activities associated with different stages within the supply chain of naturopathy using active ingredients and cell therapy.

 

Cordero GmbH & Co. KG is a company with limited liability, established in April 2013, headquartered in Bingen Germany and managed by Stephanie Dreyer. Cordero specialises in the production of lyophilisates and cell peptides from animal material as well as the acquisition and management of property.

 

Humanio GmbH is a company with limited liability established in April 2013 and represented by Managing Director Stephanie Dreyer. Humanio is involved in the operation of a day clinic for biological medicine, including the provision of accommodation and meals to patients. The Humanio institution is situated in a stately home in Bingen which incorporates a cell therapy clinic and also an analysis laboratory for the production of internationally sought-after cell preparations (for which the property and IP is owned by Cordero GmbH& Co. KG).

 

WTS plc has come to an arrangement with these companies to bring clients from China to the Humanio clinic, to assist in the Chinese food product registration for Naturemed capsules and supplements and consequently sell these Naturemed products in the Chinese market under the WTS brand.

WTS plc believes that through partnering with these companies, mutually beneficial collaborations can be achieved as aligned with the overarching vision of WTS plc as a 'gateway to China' by expanding its portfolio of foreign health companies.

The UK headquarters has signed a new five year lease for a permanent office establishment and will move its business office to these expanded premises during January 2018. Additionally, WTS plc is in discussions to house synergistic partner companies within this headquarter office in Amersham, London, to enable increased collaboration on joint projects which are currently being pursued (please refer to Announcements dated 03 April 2017 and 17 May 2017).

The Board of WTS plc is actively seeking strategic synergistic partners to diversify its income base and reduce its reliance on the WTS China and are pleased to provide this update.

 

For more information, please contact the following:

World Trade Systems plc

Mr. AKM Ismail, Executive Director, akm.ismail@gmail.com

 

Information on WTS plc

WTS plc is a global health company headquartered in the UK with a vision to be a 'gateway to China for foreign health food companies. Currently WTS's main business operations are the development, and distribution of health food products targeting mid/high end consumers. Having previously had no business activities for a number of years, the Company began its current business activities in July of 2016 when WTS China was established and began operations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRTTBATMBATBRR
12
Date   Source Headline
20th Feb 202012:43 pmRNSCancellation of Listing
23rd Jul 20194:38 pmRNSClarification
4th Mar 20194:43 pmRNSAcquiring 28.56 pct in World Trade Systems plc
28th Sep 201812:54 pmRNSHalf-year Report
9th Jul 20189:51 amRNS2018 AGM Results
8th Jun 20181:31 pmRNSNotice of AGM
15th May 20182:51 pmRNSMOU and Update on IBD
4th May 201811:26 amRNSDirector Resignation
9th Apr 20188:25 amRNS2017 Annual Financial Report
12th Mar 201812:05 pmRNSMARCH UPDATE
17th Jan 201812:26 pmRNSUpdate on listing, new business and address
27th Dec 20177:00 amRNSUpdate on new business activity
7th Aug 20177:00 amRNS4 August 2017 GM results
2nd Aug 20172:10 pmRNSHalf-year Report
2nd Aug 20171:48 pmRNSHalf-year Report
18th Jul 20176:03 pmRNSCircular
18th Jul 20175:55 pmRNSNOTICE OF CIRCULAR AND DEED OF WAIVER
12th Jul 20175:54 pmRNSARTICLES OF ASSOCIATION adopted on 29th June 2017
30th Jun 201710:47 amRNSAGM Statement
26th Jun 201710:03 amRNSDirectorate Resignation
2nd Jun 20177:00 amRNSNotice of AGM
25th May 20177:00 amRNSR&D and market distribution co-operation
22nd May 20177:00 amRNSR&D, Product Diversification
8th May 20177:00 amRNSDirectorate Change
25th Apr 20176:29 pmRNSFinal Results 2016
3rd Apr 20175:42 pmRNSR&D, Product Diversification
20th Dec 20164:32 pmRNSStatement re Interim Accounts
16th Nov 201612:04 pmRNSStatus Update - Replacement
15th Nov 20163:21 pmRNSMiscellaneous - Status Update
28th Oct 20165:33 pmRNSChange of Secretary and Registered Office
20th Oct 20161:00 pmRNSAGM Statement
22nd Aug 201610:08 amRNSCorrection to Chairman's letter to Shareholders
22nd Aug 201610:00 amRNSCorrection to Notice of GM
17th Aug 20163:36 pmRNSChairman's letter to shareholders - 2016 AGM
17th Aug 20163:14 pmRNSNotice of AGM
16th Aug 20165:15 pmRNSAnnual Financial Report
18th May 20167:00 amRNSStatus Update
15th Feb 20164:45 pmRNSAnnouncement of New Business Activity
21st May 20155:54 pmRNSResult of AGM
21st May 20153:34 pmRNSAnnual Financial Report
11th Apr 20134:29 pmRNSResult of AGM
4th Feb 201310:58 amRNSFinal Results
25th Jul 201211:57 amRNSHalf Yearly Report
7th Mar 20124:32 pmRNSAGM Statement
3rd Feb 20123:00 pmRNSAnnual Financial Report
21st Mar 20113:11 pmRNSResult of AGM
24th Jan 201110:06 amRNSAnnual Financial Report
5th Aug 20102:45 pmRNSStatement re. Suspension
29th Jun 20103:12 pmRNSResult of AGM
25th Jun 201010:48 amRNSHalf Yearly Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.